Cited by 105

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Association of Aortic Atherosclerosis with Cerebral β-Amyloidosis and Learning Deficits in a Mouse Model of Alzheimer's Disease

Li, Ling, Cao, Dongfeng, Garber, David W., Kim, Helen, Fukuchi, Ken-ichiro·2003·The American Journal of Pathology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0002-9440(10)63572-9

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 42

  1. Sparks, 1990, Cortical senile plaques in coronary artery disease, aging, and Alzheimer's disease, Neurobiol Aging, 11, 601, 10.1016/0197-4580(90)90024-T · DOI
  2. Corder, 1993, Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families, Science, 261, 921, 10.1126/science.8346443 · DOI · Paper page
  3. Notkola, 1998, Serum total cholesterol, apolipoprotein E ɛ 4 allele, and Alzheimer's disease, Neuroepidemiology, 17, 14, 10.1159/000026149 · DOI
  4. Kuo, 1998, Elevated low-density lipoprotein in Alzheimer's disease correlates with brain aβ 1–42 levels, Biochem Biophys Res Commun, 252, 711, 10.1006/bbrc.1998.9652 · DOI · Paper page
  5. Caramelli, 1999, Increased apolipoprotein B serum concentration in Alzheimer's disease, Acta Neurol Scand, 100, 61, 10.1111/j.1600-0404.1999.tb00724.x · DOI · Paper page
  6. Merched, 2000, Decreased high-density lipoprotein cholesterol and serum apolipoprotein AI concentrations are highly correlated with the severity of Alzheimer's disease, Neurobiol Aging, 21, 27, 10.1016/S0197-4580(99)00103-7 · DOI
  7. Wolozin, 2000, Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors, Arch Neurol, 57, 1439, 10.1001/archneur.57.10.1439 · DOI
  8. Jick, 2000, Statins and the risk of dementia, Lancet, 356, 1627, 10.1016/S0140-6736(00)03155-X · DOI
  9. Sparks, 1994, Induction of Alzheimer-like β-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol, Exp Neurol, 126, 88, 10.1006/exnr.1994.1044 · DOI · Paper page
  10. Refolo, 2000, Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model, Neurobiol Dis, 7, 321, 10.1006/nbdi.2000.0304 · DOI · Paper page
  11. Shie, 2002, Diet-induced hypercholesterolemia enhances brain Aβ accumulation in transgenic mice, Neuroreport, 13, 455, 10.1097/00001756-200203250-00019 · DOI · Paper page
  12. Levin-Allerhand, 2002, Increased amyloid-levels in APPSWE transgenic mice treated chronically with a physiological high-fat high-cholesterol diet, J Nutr Health Aging, 6, 315
  13. Breslow, 1996, Mouse models of atherosclerosis, Science, 272, 685, 10.1126/science.272.5262.685 · DOI · Paper page
  14. Selkoe, 1987, Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease, Science, 235, 873, 10.1126/science.3544219 · DOI · Paper page
  15. Carlson, 1997, Genetic modification of the phenotypes produced by amyloid precursor protein overexpression in transgenic mice, Hum Mol Genet, 6, 1951, 10.1093/hmg/6.11.1951 · DOI · Paper page
  16. Hsiao, 1996, Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice, Science, 274, 99, 10.1126/science.274.5284.99 · DOI · Paper page
  17. Paigen, 1990, Atherosclerosis susceptibility differences among progenitors of recombinant inbred strains of mice, Arteriosclerosis, 10, 316, 10.1161/01.ATV.10.2.316 · DOI
  18. Garber, 2000, A sensitive and convenient method for lipoprotein profile analysis of individual mouse plasma samples, J Lipid Res, 41, 1020, 10.1016/S0022-2275(20)32045-9 · DOI
  19. Paigen, 1987, Quantitative assessment of atherosclerotic lesions in mice, Atherosclerosis, 68, 231, 10.1016/0021-9150(87)90202-4 · DOI
  20. Fukuchi, 1998, Amyloid-β deposition in skeletal muscle of transgenic mice: possible model of inclusion body myopathy, Am J Pathol, 153, 1687, 10.1016/S0002-9440(10)65682-9 · DOI
  21. Lalonde, 2002, Transgenic mice expressing the human C99 terminal fragment of βAPP: effects on spatial learning, exploration, anxiety, and motor coordination, Exp Gerontol, 37, 1401, 10.1016/S0531-5565(02)00123-7 · DOI
  22. Takeuchi, 2000, Age-related amyloid β deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid β precursor protein Swedish mutant is not associated with global neuronal loss, Am J Pathol, 157, 331, 10.1016/S0002-9440(10)64544-0 · DOI · Paper page
  23. Hofman, 1997, Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study, Lancet, 349, 151, 10.1016/S0140-6736(96)09328-2 · DOI · Paper page
  24. Bodovitz, 1996, Cholesterol modulates α-secretase cleavage of amyloid precursor protein, J Biol Chem, 271, 4436, 10.1074/jbc.271.8.4436 · DOI · Paper page
  25. Simons, 1998, Cholesterol depletion inhibits the generation of β-amyloid in hippocampal neurons, Proc Natl Acad Sci USA, 95, 6460, 10.1073/pnas.95.11.6460 · DOI
  26. Frears, 1999, The role of cholesterol in the biosynthesis of β-amyloid, Neuroreport, 10, 1699, 10.1097/00001756-199906030-00014 · DOI
  27. Fassbender, 2001, Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ 42 and Aβ 40 in vitro and in vivo, Proc Natl Acad Sci USA, 98, 5856, 10.1073/pnas.081620098 · DOI · Paper page
  28. Kojro, 2001, Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the α-secretase ADAM 10, Proc Natl Acad Sci USA, 98, 5815, 10.1073/pnas.081612998 · DOI · Paper page
  29. Howland, 1998, Modulation of secreted β-amyloid precursor protein and amyloid β-peptide in brain by cholesterol, J Biol Chem, 273, 16576, 10.1074/jbc.273.26.16576 · DOI
  30. Dehouck, 1997, A new function for the LDL receptor: transcytosis of LDL across the blood-brain barrier, J Cell Biol, 138, 877, 10.1083/jcb.138.4.877 · DOI · Paper page
  31. Refolo, 2001, A cholesterol-lowering drug reduces β-amyloid pathology in a transgenic mouse model of Alzheimer's disease, Neurobiol Dis, 8, 890, 10.1006/nbdi.2001.0422 · DOI
  32. Segrest, 2000, Structure and function of apolipoprotein A-I and high-density lipoprotein, Curr Opin Lipidol, 11, 105, 10.1097/00041433-200004000-00002 · DOI
  33. Biere, 1996, Amyloid β-peptide is transported on lipoproteins and albumin in human plasma, J Biol Chem, 271, 32916, 10.1074/jbc.271.51.32916 · DOI · Paper page
  34. Koudinov, 1996, Biochemical characterization of Alzheimer's soluble amyloid β protein in human cerebrospinal fluid: association with high density lipoproteins, Biochem Biophys Res Commun, 223, 592, 10.1006/bbrc.1996.0940 · DOI
  35. Cole, 1999, Lipoprotein effects on Aβ accumulation and degradation by microglia in vitro, J Neurosci Res, 57, 504, 10.1002/(SICI)1097-4547(19990815)57:4<504::AID-JNR10>3.0.CO;2-H · DOI
  36. Urmoneit, 1997, Cerebrovascular smooth muscle cells internalize Alzheimer amyloid β protein via a lipoprotein pathway: implications for cerebral amyloid angiopathy, Lab Invest, 77, 157
  37. Kivipelto, 2001, Midlife vascular risk factors and late-life mild cognitive impairment: a population-based study, Neurology, 56, 1683, 10.1212/WNL.56.12.1683 · DOI · Paper page
  38. Stewart, 2001, Vascular risk and cognitive impairment in an older, British, African-Caribbean population, J Am Geriatr Soc, 49, 263, 10.1046/j.1532-5415.2001.4930263.x · DOI
  39. Engelhart, 2002, Diet and risk of dementia: does fat matter?: The Rotterdam Study, Neurology, 59, 1915, 10.1212/01.WNL.0000038345.77753.46 · DOI · Paper page
  40. Morris, 2003, Dietary fats and the risk of incident Alzheimer disease, Arch Neurol, 60, 194, 10.1001/archneur.60.2.194 · DOI
  41. Greenwood, 1996, Cognitive impairment in rats fed high-fat diets: a specific effect of saturated fatty-acid intake, Behav Neurosci, 110, 451, 10.1037/0735-7044.110.3.451 · DOI
  42. De Meyer, 2002, Platelet phagocytosis and processing of β-amyloid precursor protein as a mechanism of macrophage activation in atherosclerosis, Circ Res, 90, 1197, 10.1161/01.RES.0000020017.84398.61 · DOI

Cited by

Sorted by citations

Metadata

Authors
Li, L., Cao, D., Garber, D. W., Kim, H., & Fukuchi, K.-I.
Venue
The American Journal of Pathology
Publisher
Elsevier BV
Published
2003-12
Volume
163
Issue
6
Pages
2155-2164
ISSN
0002-9440
Cited by
105
References
3
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review